Noxopharm Limited (ASX:NOX), a clinical-stage Australian biotech company, has advised it will hold an Extraordinary General Meeting (EGM) as a physical meeting at Level 5, 126 Phillip Street, Sydney NSW 2000 at 1:00pm AEDT on Wednesday, 16 December 2026, with nine resolutions on the agenda including approval to convert convertible notes at $0.042 per share.

Key Points

  • EGM scheduled for 16 December 2026 at 1:00pm AEDT at Level 5, 126 Phillip Street, Sydney NSW 2000
  • Nine resolutions tabled, including approval to convert convertible notes held by non-related and related parties at $0.042 per share
  • Resolution 2 seeks approval to convert a convertible note held by 4F Investments Pty Limited, an associated entity of director Mr Fred Bart, at $0.042 per share
  • Resolutions also cover ratification and approval of placement shares, attaching options, piggyback options, and lead manager options
  • Proxy instructions must be received no later than 48 hours before the meeting commencement to be valid

EGM Date, Venue and Participation

Noxopharm disclosed the EGM will be conducted as a physical meeting in a manner consistent with its Constitution and the Corporations Act 2001. Shareholders may attend in person at Level 5, 126 Phillip Street, Sydney NSW 2000 on 16 December 2026 at 1:00pm AEDT. The Notice of Meeting was prepared based on circumstances as at 11 November 2026, and the filing was signed by Company Secretary Shawn van Boheemen on 17 November 2026. The full Notice of EGM is available on the ASX market announcements platform.

Nine Resolutions Including Related-Party Matters

The EGM agenda contains nine resolutions. Resolution 1 seeks approval to convert convertible notes held by non-related parties at $0.042 per share. Resolution 2 seeks approval to convert a convertible note held by 4F Investments Pty Limited, an associated entity of director Mr Fred Bart, at the same price of $0.042 per share. Resolution 3 covers ratification of the issue of placement shares under Listing Rule 7.1 capacity. Resolution 4 seeks approval to issue placement shares to N&J Properties Pty Ltd, an associate of Mr Fred Bart. Resolutions 5 through 9 address the issuance of attaching options, piggyback options to placement participants and to N&J Properties Pty Ltd, and lead manager options respectively.

Proxy Voting Procedures and Deadline

Shareholders unable to attend in person may vote by proxy. The filing states that proxy instructions can be lodged online, by post to Automic at GPO Box 5193 Sydney NSW 2001, by hand at Level 5, 126 Phillip Street Sydney NSW 2000, or by email to the company's registry. Personalised proxy forms have been provided to each shareholder. The filing states that proxy instructions must be received no later than 48 hours before the commencement of the meeting, and that proxy forms received after this time will be invalid.